Laboratory Services
Antinuclear Antibodies, HEp-2 Substrate, IgG, Serum
Print this pageUpdated Test Information:
Test Description |
Antinuclear Antibodies, HEp-2 Substrate, IgG, Serum
|
|
---|---|---|
Synonym(s) |
ANA (Antinuclear Antibodies); Antinuclear Antibodies (ANA), HEp-2 substrate, Serum; LE (Lupus Erythematosus) Prep; Antinuclear Antibody, Serum; ANA IFA; ANA IF |
|
Test ID |
NAIFA
|
|
General Information |
Useful for evaluating patients suspected of having systemic rheumatic disease |
|
Specimen Type |
Serum |
|
Specimen Requirements |
|
|
Minimum Sample Volume |
0.3 mL |
|
Stability |
|
|
Limitations |
Some patients without clinical evidence of an autoimmune disease or a systemic rheumatic disease may have a detectable level of antinuclear antibody (ANA). This finding is more common in women than men and the frequency of a detectable ANA in healthy women over 40 years of age may approach 15% to 20%. ANA may also be detectable following viral illnesses, in chronic infections, or in patients treated with many different medications. |
|
Methodology |
Indirect Immunofluorescence |
|
Estimated TAT |
1-2 days |
|
Testing Schedule |
Monday-Saturday |
|
Test Includes |
|
|
Retention |
14 days |
|
CPT Code(s) |
86039 |
|
Reference Range |
<1:80 (Negative) |
|
Performing Lab |
Mayo |
|
LOINC Code(s) |
59069-5, 33253-6, 49311-4, 33253-6, 49311-4, 55171-3, 77202-0 |
|
Additional Information |